Hybrid cardiac imaging techniques enhance coronary artery disease diagnosis, physiologic assessment, risk stratification, and ...

In this article, we will look at the 7 Best Pharma Stocks to Invest In Now. On March 24, Scott Chronert, Citi, appeared on CNBC’s ‘Closing Bell’ to talk about the market and whether it is time to get ...

Decades later, a kidney disease that was likely set off by that illness finally took its toll—and I was in kidney failure, ...

PepGen Inc. shares plunged about 65% after mixed Phase 2 data for PGN-EDODM1 in DM1, with no functional improvement at 5 ...

Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, ...

From eating dinner earlier to taking shots of olive oil, I tried to find out which longevity habits are a waste of time and ...

The company's Biomea that is the lead program, icovamenib, is the first in the category of menin inhibitors directed to the treatment of both type 1 and type 2 diabetes that holds the potential to ...

Showcase Furniture, a prominent provider of residential furnishings, recently announced the addition of a significant ...

Psyvo Health utilizes evidence-based clinical interventions to reduce recidivism and transform Louisiana's justice ...

Venture capitalists are pouring money into their next big play: pet clinics and veterinary platforms. What does this mean for ...

Iptacopan significantly slowed kidney function decline over 24 months compared with placebo in adults with IgA nephropathy. The complement inhibitor was granted accelerated approved in 2024; continued ...

GLP-1-class weight-loss drugs can help users shed dozens of pounds, leading to a more active, energized life. One in eight ...